One of the most important drivers of sales force productivity and effectiveness is incentive compensation. Pharmaceutical businesses have always endeavored to recruit and retain high-performing
How important is it to plan a good compensation plan? Does it have an impact on the employees’ performance? Read this blog to know more about it.
Ever wondered why you need an automated Incentive Compensation Solution? Read this blog and find out the answers to your question.
Continuing with our analysis of clinical trials, in this blog we have focused on two important aspects of this area i.e the enrollment rates, covering the reasons for the change in the share of enrollments in particular therapeutic areas over the decade and its trends in recent years. Another important aspect is the status of trials being conducted in a particular therapeutic area with the reasons for changes that occurred.
Clinical Trials have evolved over time in many aspects. The extensive use of modern tools available has helped in increasing the rate at which the trials are being conducted in recent years. There have been an evolution in the techniques being used and the major areas of focus. Where the major focus used to be only Oncology, Respirology etc., now researchers have increased the range of trials and infiltrated into new Therapeutic areas. The Blog gives us insight into the top 5 such Therapeutic areas which were in the limelight over the past decade.
Open Payments, managed by the Centers for Medicare & Medicaid Services (CMS) is a national disclosure program that promotes a more transparent and accountable health care system. Open Payments houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and Teaching Hospitals. These payments may include consulting fees, research grants, travel reimbursements, and payments made from the industry to medical practitioners.
Clinical trials are organized exploration studies to decide if a clinical treatment, device, or system is suitable and safe to be applied to humans. This blog focuses on the overall change in the scenario of the clinical trials space since the beginning of the previous decade (2010-2020) and insights from the past three years(2017-2020). Additionally, there is some light shed on the major changes happening in different therapeutic areas, no of trials, enrollment rates, and distribution of trials across countries.
A traditional incentive payout curve delivers different payout amounts for performance between minimum (threshold) level of performance and excellence (“superior” or “stretch”) level of performance. Usually, a curve is designed with additional elements such as threshold, target slope, excellent slopes and Cap to pay out 100% of an employee’s incentive opportunity on achieving the target. This article walks you through on ways of accounting these elements while designing your payout curve right.
Qualifiers and Modifiers are a very useful plan components for incentive plan design and enables organizations to meet specific business needs. This blogpost elaborates on some of the different types of qualifiers and modifiers along with few examples.
IC plan operations is generally considered more tactical and is not given the importance it deserves. In this blogpost, we will discuss how to perform a health check for your incentive compensation operations.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
A business-ready Incentive Compensation solution that supports implementations and changes in half the time at a third of the cost.
